EDAP TMS Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St · 08/30 11:57

EDAP TMS (NASDAQ:EDAP) Second Quarter 2024 Results

Key Financial Results

  • Revenue: €15.8m (up 11% from 2Q 2023).
  • Net loss: €6.13m (loss widened by 31% from 2Q 2023).
  • €0.17 loss per share (further deteriorated from €0.13 loss in 2Q 2023).
earnings-and-revenue-growth
NasdaqGM:EDAP Earnings and Revenue Growth August 30th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

EDAP TMS Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 2.9%. Earnings per share (EPS) missed analyst estimates by 33%.

Looking ahead, revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Medical Equipment industry in the US.

Performance of the American Medical Equipment industry.

The company's shares are down 22% from a week ago.

Risk Analysis

It is worth noting though that we have found 1 warning sign for EDAP TMS that you need to take into consideration.